PainReform Ltd.
PRFX

$608.66 K
Marketcap
$5.30
Share price
Country
$-5.86
Change (1 day)
$20.16
Year High
$0.43
Year Low

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

marketcap

PainReform Ltd. (PRFX) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 45 K -7,940,000 2.69 M 9.93 M 9.8 M
2022 55 K -4,096,000 1.31 M 12.33 M 12.28 M
2021 218 K -16,537,000 991 K 19.07 M 19.02 M
2020 53 K -15,677,000 1.18 M 17.8 M 17.79 M
2019 22 K 5.23 M 6.79 M 1.16 M 972 K